2022
DOI: 10.1039/d2an00158f
|View full text |Cite
|
Sign up to set email alerts
|

Polymer-capped gold nanoparticles as nanozymes with improved catalytic activity for the monitoring of serum ciprofloxacin

Abstract: PAM@AuNPs showed enzyme-simulation characteristic in TMB oxidation. Upon the improvement of its POD-like activity by drug CIP, a protocol for the selective and sensitive monitoring of CIP in rat-serum was constructed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…These nanocarriers need to be sensitive to external (light, ultrasound, and magnetic field) or internal (pH, redox, and enzyme) stimuli, for their cargo release [105]. Therefore, even though NPs have been used in the clinical setting since the early1990s, the tremendous potential for developing novel disease-specific treatments with reduced side effects (due to their controlled release) has to be accompanied with increasing concerns about their biosafety; this has reduced the number of NPs approved for diagnosis to only one type, namely iron oxide NPs [2,3,[21][22][23][24][25][26][27].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These nanocarriers need to be sensitive to external (light, ultrasound, and magnetic field) or internal (pH, redox, and enzyme) stimuli, for their cargo release [105]. Therefore, even though NPs have been used in the clinical setting since the early1990s, the tremendous potential for developing novel disease-specific treatments with reduced side effects (due to their controlled release) has to be accompanied with increasing concerns about their biosafety; this has reduced the number of NPs approved for diagnosis to only one type, namely iron oxide NPs [2,3,[21][22][23][24][25][26][27].…”
Section: Discussionmentioning
confidence: 99%
“…NPs have been used in the clinic setting as drug delivery systems since the early 1990s [21]. Among the NP formulations designed and tested in recent years, we find gold nanoparticles [22], ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles [23], nanotubes [24], and nanoparticles encapsulated in liposomes [25], polymers, and micelles [26,27].…”
Section: Nps As Drug Delivery Systemsmentioning
confidence: 99%
“…Gold nanoclusters (AuNCs) have ultrasmall sizes (≤2 nm), unique electronic structures, and molecule-like properties. , Thus, they have been widely applied in bionics, biosensing, biomedicine, and particularly mimetic catalysis. , Significant progress of nanomimetic enzymes has been developed to conquer the boundedness of natural enzymes such as instability, high cost, complex purification, and transportation. , Compared with other materials simulating enzymatic activity, AuNCs process the merits of ultrasmall size, nontoxicity, good stability, and biocompatibility . In addition, AuNCs have been used to catalyze H 2 O 2 to produce ROS in vitro and in cells. The primary process involves the adsorption of H 2 O 2 at the gold surface, and the O–O bonds are broken into dihydroxy radicals; meanwhile, the gold core further stabilizes the generated hydroxyl radicals through partial electron exchange. It enables AuNCs with excellent catalytic capacities for ROS generation.…”
Section: Introductionmentioning
confidence: 99%